Cordis US Executive and Leadership Team

Duke Rohlen, the Chief Executive Officer at Cordis US, directs the company's overall strategic vision and operational execution. With over 60 years of Cordis's experience in interventional cardiovascular technologies, Rohlen guides the development and manufacturing of minimally invasive devices. This leadership encompasses guidewires, catheters, balloons, stents, and vascular closure systems, all designed to treat coronary and peripheral vascular diseases. Rohlen ensures the company maintains its market leadership by fostering innovation and driving the expansion of its product portfolio. The Chief Executive Officer's role involves aligning all departments toward achieving the company's mission of improving patient lives through advanced medical solutions. By overseeing global strategy, Duke Rohlen ensures Cordis US remains at the forefront of cardiovascular care, addressing critical needs in both established and emerging markets.

Hernan Domenico, the Head Chief Financial Officer, Finance (Americas) at Cordis US, manages all financial operations and strategic fiscal planning for the Americas region. Domenico oversees budgeting, forecasting, and financial reporting, ensuring robust financial health and compliance. This role is critical in supporting the company's growth initiatives and its specialization in interventional cardiovascular technologies. The Chief Financial Officer's responsibilities include optimizing financial performance, managing capital allocation for research and development of minimally invasive devices, and ensuring profitability across product lines such as guidewires, catheters, balloons, stents, and vascular closure systems. Hernan Domenico's financial acumen directly supports the company's objective to treat coronary and peripheral vascular diseases effectively. By providing essential financial insights, Domenico enables strategic decision-making that drives Cordis US's market position and long-term sustainability in the medical device sector.

Bryan Loo, the President, Asia Pacific at Cordis US, directs the company's strategic operations and market expansion across the Asia Pacific region. Loo oversees the sales, marketing, and distribution of Cordis's interventional cardiovascular technologies, ensuring alignment with global objectives. This leadership role is crucial for driving growth and market penetration for minimally invasive devices, including guidewires, catheters, balloons, stents, and vascular closure systems, within diverse Asian markets. The President, Asia Pacific focuses on understanding regional healthcare needs and adapting strategies to effectively treat coronary and peripheral vascular diseases. Bryan Loo's management ensures that Cordis US maintains a strong presence and delivers innovative medical solutions tailored to the specific demands of the Asia Pacific healthcare landscape, reinforcing the company's commitment to patient care.

Matthew Muscari, the President, Americas at Cordis US, spearheads the company's commercial strategy and operational execution throughout North and South America. Muscari drives the sales and market development for Cordis's extensive portfolio of interventional cardiovascular technologies, focusing on expanding access to minimally invasive devices. This includes guidewires, catheters, balloons, stents, and vascular closure systems, all critical for treating coronary and peripheral vascular diseases. The President, Americas ensures that regional teams effectively serve healthcare providers and patients, fostering strong relationships and delivering value. Matthew Muscari's leadership is instrumental in achieving business objectives, enhancing market share, and reinforcing Cordis US's position as a leader in cardiovascular care across the Americas, leveraging over 60 years of company expertise.

Nancy Pounder, the Chief Human Resources Officer at Cordis US, leads all human capital strategies and organizational development initiatives. Pounder is responsible for cultivating a high-performance culture that supports the company's focus on interventional cardiovascular technologies and its mission to develop advanced medical devices. This includes talent acquisition, employee engagement, compensation and benefits, and leadership development programs designed to attract and retain top talent in the medical device industry. The Chief Human Resources Officer ensures that Cordis US has the skilled workforce necessary to innovate and manufacture minimally invasive devices like guidewires, catheters, balloons, stents, and vascular closure systems. Nancy Pounder's strategic direction in human resources is vital for supporting the company's efforts to treat coronary and peripheral vascular diseases and maintain its legacy of over 60 years of experience.